Regulatory consulting firm providing FDA U.S. Agent services for foreign establishments, including registration, listing, communication with FDA, and inspection / compliance support.
DSI (DS InPharmatics) provides FDA U.S. Agent services for international pharmaceutical companies and other FDA-regulated products. They act as the required point of contact between foreign establishments and the FDA, handling establishment registration, product listing, regulatory communications, inspection coordination, and compliance support. DSI serves as your trusted U.S. Agent, ensuring adherence to all relevant FDA regulations and serving as a dependable liaison between your organization and the FDA.
About
**Who they are** DSI (US Agent Services), a ProductLife Group company, is a regulatory, technical, and project management consulting firm established in 2007. They specialize in providing services to healthcare product companies that manufacture and/or market pharmaceuticals, biopharmaceuticals, and cellular and gene therapy products.
**Expertise & scope** * Regulatory consulting for pharmaceuticals, biologics, and new drug and delivery platforms. * Chemistry, Manufacturing, and Controls (CMC) strategy, operations, and submission content development. * Support for product development, regulatory compliance, and project management challenges. * Assistance with investigational applications, New Drug Applications (NDAs/BLAs), and post-approval lifecycle maintenance. * Expertise in navigating regulatory pathways, including FDA Center for Veterinary Medicine (CVM) and USDA Center for Veterinary Biologics (CVB) for veterinary products. * Services extend to early engagement, pricing strategy, health economics, and outcomes research.
**Reputation / proof points** * Founded in 2007. * Partnered with over 200 unique sponsors globally. * Contributed to over 100 investigational applications and 25 NDAs/BLAs. * Part of ProductLife Group since April 2021.
Additional information
DSI InPharmatics emphasizes a phase-appropriate, expertise-driven approach to drug development consulting. They focus on providing pragmatic, field-tested viewpoints to guide new products from pre-IND stages through clinical trials to regulatory approvals and post-approval maintenance. Their methodology involves open exchange of information and directness, offering authentic assessments, representative timelines, dependable technical advice, and truthful submissions based on current and forward-thinking regulatory strategies. They aim to act as an extension of a client's internal team, providing a 'deeper department' level of support.
Key Highlights
Founded in 2007, DSI InPharmatics has over a decade of experience in regulatory drug development consulting.
Source
“Founded in 2007 by Edward Narke and Anthony Durning...”
Has partnered with over 200 unique sponsors globally, contributing to over 100 investigational applications and 25 NDAs/BLAs.
Source
“Over the last decade, we have partnered with more than 200 unique sponsors not only here in the US but globally...”
Provides specialized support for veterinary drug and biologic approvals, navigating FDA CVM and USDA CVB pathways.
Source
“Navigating the regulatory landscape for veterinary pharmaceuticals and biologics can be complex.”
Acts as a ProductLife Group company, leveraging a broader network and resources.
Source
“DS InPharmatics
a ProductLife Group Company”
Certifications & Trust Signals
Established in 2007, indicating significant experience in the field.
Source
“Founded in 2007 by Edward Narke and Anthony Durning...”
Part of the ProductLife Group, suggesting a robust organizational backing.
Source
“DS InPharmatics
a ProductLife Group Company”
Buyer Snapshot
Best for
Companies developing pharmaceuticals, biopharmaceuticals, and cellular/gene therapies.
Emerging biotech firms needing CMC and regulatory strategy support.
Foreign establishments requiring FDA U.S. Agent services.
How engagement typically works
Direct and open communication.
Authentic assessment and truthful submissions.
Providing a 'deeper department' level of support.
Typical deliverables
Regulatory strategy development.
CMC submission content.
Investigational and marketing application support.
Post-approval lifecycle maintenance.
FDA U.S. Agent services.
Good to know
Best when a provider with deep regulatory and project management experience is needed.
Suitable for clients seeking a partner with a proven track record in drug development.
Included services: FDA communications handling, Inspection scheduling coordination, Registration support, Annual renewal reminders
Product Type: drugs
Service Types: US Agent Services, FDA Registration/Listing Support, Inspection Support, FDA Submissions (510(k), PMA, IDE, etc.), Product/Device Listing, Regulatory Consulting
Additional us_agent_fda Details
Included Services Detailed
Designation support and onboarding checklist for foreign establishment U.S. Agent setup, FDA communications receipt, acknowledgment, and routing to your designated contacts, Inspection scheduling support and operational readiness escalation (when applicable), Annual registration renewal reminders and administrative coordination
Excluded Services
Acting as importer of record, Commercial distribution management, Legal representation in enforcement actions
Onboarding Steps
Engage early with regulatory authorities, develop a comprehensive regulatory strategy, streamline manufacturing and quality control.
Coverage Details
U.S.-based agent coverage with defined business-hours availability and escalation path (seed summary).